By integrating advances across neuroimmunology and systems biology, this work establishes a temporally sequenced targeting strategy for CX3CR1 modulation, providing a foundational framework for next-generation precision stroke therapeutics. The gene discussed is CX3CR1; the disease is stroke disorder.